124 related articles for article (PubMed ID: 38234119)
21. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
22. Potential prognostic value of a eight ferroptosis-related lncRNAs model and the correlative immune activity in oral squamous cell carcinoma.
Qiu L; Tao A; Liu F; Ge X; Li C
BMC Genom Data; 2022 Nov; 23(1):80. PubMed ID: 36384476
[TBL] [Abstract][Full Text] [Related]
23. Establishment and Analysis of Hypoxia-Related Model in Oral Squamous Cell Carcinoma.
Lu X; Liu X
J Healthc Eng; 2022; 2022():6602648. PubMed ID: 35432823
[TBL] [Abstract][Full Text] [Related]
24. Decreased CSTA expression promotes lymphatic metastasis and predicts poor survival in oral squamous cell carcinoma.
Wang Y; Wang L; Li X; Qu X; Han N; Ruan M; Zhang C
Arch Oral Biol; 2021 Jun; 126():105116. PubMed ID: 33831734
[TBL] [Abstract][Full Text] [Related]
25. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
26. Identification of an Immune Score-Based Gene Panel with Prognostic Power for Oral Squamous Cell Carcinoma.
Huang SN; Li GS; Zhou XG; Chen XY; Yao YX; Zhang XG; Liang Y; Li MX; Chen G; Huang ZG; Dang YW; Li J; Li P; Tang XZ; Rong MH
Med Sci Monit; 2020 Jun; 26():e922854. PubMed ID: 32529991
[TBL] [Abstract][Full Text] [Related]
27. A Prognostic Model Based on Cisplatin-Resistance Related Genes in Oral Squamous Cell Carcinoma.
Lu R; Yang Q; Liu S; Sun L
Oral Health Prev Dent; 2024 Jan; 22():39-50. PubMed ID: 38223960
[TBL] [Abstract][Full Text] [Related]
28. Screening and identification of autophagy-related biomarkers for oral squamous cell carcinoma (OSCC) via integrated bioinformatics analysis.
Huang GZ; Lu ZY; Rao Y; Gao H; Lv XZ
J Cell Mol Med; 2021 May; 25(9):4444-4454. PubMed ID: 33837652
[TBL] [Abstract][Full Text] [Related]
29. Development of a novel senescence-related gene signature to predict clinical outcomes, immune landscape, and chemotherapeutic sensitivity in oral squamous cell carcinoma.
Wang A; Xiao N; Wang H; Yao Q; Li J; Wu Y; Ge H; Diao P
Head Neck; 2024 May; 46(5):1112-1125. PubMed ID: 38380567
[TBL] [Abstract][Full Text] [Related]
30. Identification of prognostic genes in oral squamous cell carcinoma microenvironment.
Zhu L; Zhang X; Chen Y; Yan D; Han J
Cancer Biomark; 2022; 34(4):523-532. PubMed ID: 35275524
[TBL] [Abstract][Full Text] [Related]
31. M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT.
Huang GZ; Wu QQ; Zheng ZN; Shao TR; Chen YC; Zeng WS; Lv XZ
Aging (Albany NY); 2020 Jun; 12(12):11667-11684. PubMed ID: 32526707
[TBL] [Abstract][Full Text] [Related]
32. A novel 4-gene signature model simultaneously predicting malignant risk of oral potentially malignant disorders and oral squamous cell carcinoma prognosis.
Zhang X; Yang M; Liu Y; Liu H; Yang J; Luo J; Zhou H
Arch Oral Biol; 2021 Sep; 129():105203. PubMed ID: 34252587
[TBL] [Abstract][Full Text] [Related]
33. Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma.
Zhang S; Wu X; Diao P; Wang C; Wang D; Li S; Wang Y; Cheng J
J Cell Physiol; 2020 May; 235(5):4804-4813. PubMed ID: 31637730
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes.
Ren Z; Zhang L; Ding W; Luo Y; Shi Z; Shrestha B; Kan X; Zhang Z; Ding J; He H; Hu X
Genomics; 2021 Jan; 113(1 Pt 2):1166-1175. PubMed ID: 33227411
[TBL] [Abstract][Full Text] [Related]
35. A novel pyroptosis-related signature predicts prognosis and indicates immunotherapy in oral squamous cell carcinoma.
Gao Y; Zhang X; Li Y; Gao J; Liu S; Cai H; Zhang J
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12057-12070. PubMed ID: 37421458
[TBL] [Abstract][Full Text] [Related]
36. Prognostic biomarkers and therapeutic targets in oral squamous cell carcinoma: a study based on cross-database analysis.
Yang W; Zhou W; Zhao X; Wang X; Duan L; Li Y; Niu L; Chen J; Zhang Y; Han Y; Fan D; Hong L
Hereditas; 2021 Apr; 158(1):15. PubMed ID: 33892811
[TBL] [Abstract][Full Text] [Related]
37. A N6-methyladenosine-related long noncoding RNAs model for predicting prognosis in oral squamous cell carcinoma: Association with immune cell infiltration and tumor metastasis.
Yang Q; Cheng C; Zhu R; Guo F; Lai R; Liu X; Li M
Oral Oncol; 2022 Apr; 127():105771. PubMed ID: 35189585
[TBL] [Abstract][Full Text] [Related]
38. Identification of Biological Functions and Prognostic Value of NNMT in Oral Squamous Cell Carcinoma.
Zhang W; Jing Y; Wang S; Wu Y; Sun Y; Zhuang J; Huang X; Chen S; Zhang X; Song Y; Hu Q; Ni Y
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291696
[TBL] [Abstract][Full Text] [Related]
39. Genetic Cross-Talk between Oral Squamous Cell Carcinoma and Type 2 Diabetes: The Potential Role of Immunity.
Fan Y; Zhang J; Shi J; Chen L; Long J; Zhang S; Liu S
Dis Markers; 2022; 2022():6389906. PubMed ID: 35634436
[TBL] [Abstract][Full Text] [Related]
40. IGF2BP2 maybe a novel prognostic biomarker in oral squamous cell carcinoma.
Wang X; Xu H; Zhou Z; Guo S; Chen R
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35129592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
